The ob/gyn's armamentarium for contraception continues to expand, with the addition of several new sustained-release devices that may increase patient satisfaction and compliance.
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More